Because I'm bored at the moment and I'm also interested in your opinion, I'll throw a few titles in here that I think are all very exciting and usually fly under the radar.

Here we go 👇

$CORT (-1,19 %) Corcept Therapeutics

$HALO (+1,52 %) Halozyme Therapeutics

$KRI (+0,16 %) Kri Kri Milk Industry

$ALCRB (-6,27 %) Carbios

$APH (-2,64 %) Amphenol

$XYL (-1,54 %) Xylem

$MPWR (+1,5 %) Monolithic Power Systems

$VITL (-1,58 %) Vital Farms

These are, of course, shares from a wide variety of sectors and with different "degrees of maturity", but as I have written, I think they are all very exciting.

Do you know them all? Opinions?

P.S. I myself have Corcept, Carbios and Amphenol in my portfolio, and I follow the others more or less regularly.

My goal is to beat the market, I'm still relatively young and want to see if I can do it, if not I'll put everything in an etf in 5 years.

Regarding my portfolio, I currently have a cash ratio of 23-25% depending on the fluctuations in the last month.

Purchases of existing stocks:

I plan to increase the financial stocks by 50%, $CG (-2,39 %)
$KKR (-1,89 %)
$APO (-1,75 %)
$TPG (-1,38 %) .

In addition, a little $DMP (-0,08 %) by 25%.

Sales:

I made the mistake of wanting to $EVO (+2,21 %) and $CPRX (+2,91 %) trade, but then I was too greedy.

I am convinced of both positions in the long term but not in this size in the portfolio, which is why I will reduce both stocks by 33%.

Potential purchases:

$HALO (+1,52 %)
$CUV (+4,64 %) - Will invest a little extra, otherwise just the 33% from sale of $CPRX. Both around 50 - 50

$SL (+2,35 %) - the same as $TISG (+1,38 %)

$KSPI (-3,2 %) - about as high as $MUM (-0,16 %)

$FIH.U (-1,63 %) - about as high as $MUM (-0,16 %)

$2GB (-3,02 %) - about as high as $MUM (-0,16 %)

$M12 (+1,42 %) - about as high as $MUM (-0,16 %)

$CPR (+0,08 %)
$DGE (+0,21 %)
$RI (-0,59 %) - I'll wait and see, but I can imagine that they will develop in a similar way to the tobacco shares. Since I don't want to decide, I'll just buy three for the sum of one. And divide the amount between these 3.

In general:

I'm generally a fan of putting together baskets like with alcohol or the yacht builders.

What would you change because you see a high risk? I am relatively poorly positioned in the tech sector, do you have any other titles that I could take a closer look at in this area?

Yesterday and today I once again discovered 2 interesting stocks outside the mainstream. One is $ICE (-0,7 %) and the other $HALO (+1,52 %) . Of course I bought both with derivatives, as you would expect from me. But I also think that the shares are interesting. Does anyone else have them in their portfolio or on their watchlist?

Evotec $EVT (+1,26 %) saw its share price rise sharply today after reports emerged of a possible takeover by a US pharmaceutical group. $HALO (+1,52 %) have emerged. This news has caused the share price of the Hamburg-based biotechnology company, which specializes in drug discovery and development, to rise sharply. Analysts and investors are speculating about the strategic advantages such a deal could bring for both sides, particularly in a growing market for innovative drug research.

Personal opinion:

Should the takeover actually take place it would be a win-win situation for investors in both companies, as Evotec certainly has exciting projects underway.

Source:

https://www.t-online.de/finanzen/boerse/ticker/aktie-im-fokus-evotec-springen-hoch-moegliche-uebernahme/0DB2DE00629B99CE/

The news is based on what I personally consider to be reputable sources. However, I do not guarantee their accuracy. No advice.

"Ad hoc: Comment on media report

Hamburg - Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO)

The $EVT (+1,26 %) SE ("Company") notes with regard to a media report that, without prior contact, it received from the listed US biotechnology company$HALO (+1,52 %) Therapeutics Inc. regarding a takeover offer addressed to the shareholders of the Company with an offer price of EUR 11.00 per share. The company will carefully analyze this expression of interest, decide on further steps and inform the capital market in accordance with legal requirements.

End of the ad hoc announcement -"